Back to top
more

Owens & Minor (OMI)

(Delayed Data from NYSE)

$16.48 USD

16.48
1,898,347

+1.17 (7.64%)

Updated Jul 23, 2024 04:00 PM ET

After-Market: $16.48 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Sanghamitra Saha headshot

5 Winning Stocks Backed by the Overlooked Rising P/E Ratio

Want to try an out-of-the-box approach? Tap five stocks, namely OMI, STKL, CASY, LAZY and AXLA, with increasing P/E ratios.

Owens & Minor (OMI) Q3 Earnings and Revenues Top Estimates

Owens & Minor (OMI) delivered earnings and revenue surprises of 21.31% and 1.30%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Value Investors Buy Owens & Minor (OMI) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Why Owens & Minor (OMI) Could Beat Earnings Estimates Again

Owens & Minor (OMI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Owens & Minor (OMI) Earnings Expected to Grow: Should You Buy?

Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Owens & Minor (OMI) Flat As Market Gains: What You Should Know

In the latest trading session, Owens & Minor (OMI) closed at $42.06, marking no change from the previous day.

Owens & Minor (OMI) Stock Sinks As Market Gains: What You Should Know

Owens & Minor (OMI) closed at $42.06 in the latest trading session, marking a -0.64% move from the prior day.

Owens & Minor (OMI) Stock Sinks As Market Gains: What You Should Know

Owens & Minor (OMI) closed the most recent trading day at $41.17, moving -1.39% from the previous trading session.

Owens & Minor (OMI) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Owens & Minor (OMI) closed at $44.27, marking a -1.49% move from the previous day.

Owens & Minor (OMI) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Owens & Minor (OMI) closed at $46.01, marking a -1.65% move from the previous day.

Owens & Minor (OMI) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Owens & Minor (OMI) closed at $46.90, marking a +1.16% move from the previous day.

Medtronic's (MDT) Q4 Earnings Beat Estimates, Margins Up

Medtronic's (MDT) fourth-quarter results reflect a strong recovery in terms of elective procedures.

Why Owens & Minor (OMI) Isn't Done Growing Earnings Yet

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Owens & Minor (OMI).

Strength Seen in Owens & Minor (OMI): Can Its 36.2% Jump Turn into More Strength?

Owens & Minor (OMI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Here's Why You Should Hold on to Exact Sciences (EXAS) Stock

Investors are optimistic about Exact Sciences (EXAS) on solid first-quarter performance and strategic partnerships.

Abbott (ABT) Organic Growth Strong, Pediatric Nutrition Down

Within Medical Device, Abbott (ABT) is facing challenging conditions in terms of procedure volume.

Here's Why You Should Hold On to Zimmer Biomet (ZBH) Stock Now

Investors are optimistic about Zimmer Biomet (ZBH) on solid first-quarter results and a gradually stabilizing global musculoskeletal market.

Kinjel Shah headshot

6 Valuable Price-to-Book Stocks to Boost Your Portfolio

P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

Top Ranked Growth Stocks to Buy for May 21st

COLM, OMI, AN, and HRI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 21, 2021

Sumit Singh headshot

Add These 5 Low P/CF Stocks to Create a Value-Based Portfolio

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Boise Cascade Company (BCC), Vishay Intertechnology (VSH), Owens & Minor (OMI), Sanmina Corporation (SANM) and Invesco (IVZ) boast low P/CF ratio.

LabCorp's (LH) New Bioanalytical Lab to Boost APAC Operation

The new laboratory by LabCorp (LH) is set to enable faster data turnaround for early phase trials in Asia-Pacific markets.

Thermo Fisher (TMO) to Boost Cell Therapies With UCSF Deal

Thermo Fisher's (TMO) collaboration with UCSF will enable end-to-end solution to accelerate cell therapy development and manufacturing with new facility.

TeleFlex (TFX) Urolift Grows, Organic Sales Hit by Pandemic

On the strength of a successful 2020 campaign, Teleflex (TFX) doubles the awareness for UroLift in the targeted population of men with BPH.

LabCorp's (LH) Pixel Kit Gets EUA for Younger Population

LabCorp (LH) becomes the first major commercial laboratory to offer a COVID-19 PCR Test Home Collection Kit for children and adolescents.